Halozyme Overview

Founded 1998
Status Public
Employees 132
Stock Symbol HALO
Stock Symbol
Share Price $23.26 (As of Thursday Closing)

Halozyme General Information


Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Contact Information

Formerly Known As
Global Yacht Services
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Stock Exchange
Primary Office
  • 11388 Sorrento Valley Road
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Halozyme Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.26 $23.60 $12.71 - $25.68 $3.16B 136M 1.66M -$0.55

Halozyme Financials Summary

In Thousands,
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 2,465,194 2,423,994 1,896,972 2,774,081
Revenue 164,397 195,992 151,862 316,613
EBITDA (62,456) (56,556) (59,364) 85,755
Net Income (80,139) (72,240) (80,330) 62,971
Total Assets 492,353 565,874 440,248 519,945
Total Debt 389,430 402,587 126,380 202,351
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Halozyme Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Halozyme‘s full profile, request access.

Request a free trial

Halozyme Executive Team (33)

Name Title Board Seat Contact Info
Helen Torley President, Chief Executive Officer & Board Member
Laurie Stelzer Chief Financial Officer & Senior Vice President
Elaine Sun Chief Financial Officer & Senior Vice President
Michael LaBarre Ph.D Chief Technology Officer, Technology & Senior Vice President
Mas Matsuda Chief Compliance Officer, Senior Vice President & General Counsel

20 Former Executives

Halozyme Board Members (13)

To view Halozyme‘s full board member team, request access »
Name Representing Role Since
Bernadette Connaughton Halozyme Board Member 000 0000
Connie Matsui Self Chairman & Board Member 000 0000
Helen Torley Halozyme President, Chief Executive Officer & Board Member 000 0000
James Daly Self Board Member 000 0000
Jean-Pierre Bizzari MD Self Board Member 000 0000

5 Former Board Members